drugset
drugset / Trial / NCT01968005

Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain

NCT01968005 ↗

Phase 3 Completed 232 enrolled MEDRx USA, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate efficacy, tolerability and safety of Etoreat®(Etodolac-Lidocaine Topical Patch) in the treatment of acute low back pain (LBP).

Timeline

Start
2013-11
Primary completion
2014-05
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Etoreat Unknown — Topical

Indications

No indication recorded.